Abstract
A series of novel ligustrazinylated derivatives was designed, synthesized and evaluated for their platelet aggregation inhibition and protective effect on injured ECV-304 cells.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
